In continuation to our earlier intimation dated January 15, 2026, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Jagsonpal Pharmaceuticals Limited Q3 FY26 Earnings Conference Call held on January 22, 2026 at 5:00 P.M. for discussion of Q3 FY26 Financial Results is available on the Company's website at below link: https://www.jagsonpal.com/investor-relations/earning-calls.\r\nWe request you to take the above on record.